Ciprofloxacin solution for infusion 2024
The value below is a framework or dynamic market ceiling: the maximum
that could be spent across all call-offs, not the value of a single contract.
Aggregate figures on this site exclude these to avoid double counting.
key details
| Value | £1 |
|---|---|
| Status | complete |
| Category (CPV) | 33600000 |
| Deadline | 14 Dec 2023 |
| Contract start | 1 Mar 2024 |
| Contract end | 31 Dec 2024 |
| Procedure | selective |
| SME suitable | Yes |
| OCID | ocds-b5fd17-c7d67042-c2bc-44fe-a762-15480be4fed2 |
Award
| Supplier | Value | Date | Status |
|---|---|---|---|
| KENT PHARMA UK LIMITED | £1 | 21 Mar 2024 | active |
description
A specific procurement under a dynamic purchasing system ref CM/EMP/21/21025 for the supply of antidotes and antibiotics, for the provision of ciprofloxacin solution for infusion
Value - The contract value is withheld from publication pursuant to regulation 50(6)(a) of the Public Contracts Regulations 2015 (as amended) as its release would be contrary to the public interest.
notice history
1 notice published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 18 Apr 2024 | Award (award) | · | 594d4396-55d5-46e9-94cd-92770609087e-742153 |
more from UK Health Security Agency
- Contingent labour contract for FOI team · £59,457 · 8 Sept 2026
- Q Pulse eQMS Software and Service · £74,888 · 7 Sept 2026
- Quality control and assurance services · £500,000 · 3 Sept 2026
- Egress Protect and Egress Workspace licences · £561,600 · 3 Sept 2026
- Tenable - Vulnerability Monitoring solution · £383,572 · 3 Sept 2026
- Provision of Colony Counter ProtoCOL 3 PLUS · £16,092 · 1 Sept 2026
- Request for information - Liquid Handling Robots · 28 Aug 2026
- Service Now Licenses Renewal 26-30 · £5,678,373 · 27 Aug 2026
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.